妊娠改变白细胞介素1β表达及新冠抗体应答
研究比较33例孕妇与17例非孕妇新冠感染免疫应答,发现孕妇血中白细胞介素1β表达升高且抗受体结合域IgG和中和抗体更低,胎盘IgG转运受抑制,提示妊娠期感染以胎盘炎症和抗病毒抗体减弱为特征。
要点
- 孕妇新冠感染后血白细胞介素1β表达升高,白细胞介素6无变化。
- 孕妇抗受体结合域IgG滴度和检出中和抗体的可能性低于非孕妇。
- 感染抑制母体新冠中和抗体经胎盘转运,但新生儿Fc受体表达未受影响。
核心结论
- 妊娠期新冠感染以胎盘炎症和抗病毒抗体应答减弱为特征,可能影响治疗效果。
研究设计与样本
- 来自约翰斯·霍普金斯医院的样本:孕妇33例(新冠阳性22例、阴性11例),非孕妇17例(均阳性)。
主要发现
- 孕妇新冠检测后14天内血白细胞介素1β表达高于14天后,白细胞介素6无差异。
- 孕妇抗受体结合域IgG滴度低于非孕妇,且检出中和抗体的可能性更低。
- 感染未改变胎盘新生儿Fc受体表达,但母体新冠中和抗体转运受抑制。
临床怎么用
- 孕期新冠感染需关注抗体应答减弱对治疗疗效的潜在影响。
- 胎盘炎症对新生儿健康的长期影响需加强随访考虑。
局限性
- 样本量较小(孕妇33例、非孕妇17例),结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe acute respiratory syndrome coronavirus 2, the disease-causing pathogen of the coronavirus disease 2019 pandemic, has resulted in morbidity and mortality worldwide. Pregnant women are more susceptible to severe coronavirus disease 2019 and are at higher risk of preterm birth than uninfected pregnant women. Despite this evidence, the immunologic effects of severe acute respiratory syndrome coronavirus 2 infection during pregnancy remain understudied. OBJECTIVE: This study aimed to assess the impact of severe acute respiratory syndrome coronavirus 2 infection during pregnancy on inflammatory and humoral responses in maternal and fetal samples and compare antibody responses to severe acute respiratory syndrome coronavirus 2 among pregnant and nonpregnant women. STUDY DESIGN: Immune responses to severe acute respiratory syndrome coronavirus 2 were analyzed using samples from pregnant (n=33) and nonpregnant (n=17) women who tested either positive (pregnant, 22; nonpregnant, 17) or negative for severe acute respiratory syndrome coronavirus 2 (pregnant, 11) at Johns Hopkins Hospital. We measured proinflammatory and placental cytokine messenger RNAs, neonatal Fc receptor expression, and tetanus antibody transfer in maternal and cord blood samples. In addition, we evaluated antispike immunoglobulin G, antispike receptor-binding domain immunoglobulin G, and neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in serum or plasma collected from nonpregnant women, pregnant women, and cord blood. RESULTS: Pregnant women with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection expressed more interleukin-1 beta, but not interleukin 6, in blood samples collected within 14 days vs >14 days after performing severe acute respiratory syndrome coronavirus 2 test. Pregnant women with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection also had reduced antispike receptor-binding domain immunoglobulin G titers and were less likely to have detectable neutralizing antibody than nonpregnant women. Although severe acute respiratory syndrome coronavirus 2 infection did not disrupt neonatal Fc receptor expression in the placenta, maternal transfer of severe acute respiratory syndrome coronavirus 2 neutralizing antibody was inhibited by infection during pregnancy. CONCLUSION: Severe acute respiratory syndrome coronavirus 2 infection during pregnancy was characterized by placental inflammation and reduced antiviral antibody responses, which may impact the efficacy of coronavirus disease 2019 treatment in pregnancy. In addition, the long-term implications of placental inflammation for neonatal health require greater consideration.
引用
- Sherer ML, Lei J, Creisher PS, et al. Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection. Am J Obstet Gynecol. 2021. PMID: 33798476. doi:10.1016/j.ajog.2021.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。